103 related articles for article (PubMed ID: 2309721)
21. Drug-related visits to a district hospital emergency room.
Juntti-Patinen L; Kuitunen T; Pere P; Neuvonen PJ
Basic Clin Pharmacol Toxicol; 2006 Feb; 98(2):212-7. PubMed ID: 16445597
[TBL] [Abstract][Full Text] [Related]
22. Adverse drug reactions related hospitalization identified by discharge ICD-9 codes in a univeristy hospital in Riyadh.
Al-Malaq HM; Al-Aqeel SA; Al-Sultan MS
Saudi Med J; 2008 Aug; 29(8):1145-50. PubMed ID: 18690308
[TBL] [Abstract][Full Text] [Related]
23. Adverse drug reactions in an elderly outpatient population.
Schneider JK; Mion LC; Frengley JD
Am J Hosp Pharm; 1992 Jan; 49(1):90-6. PubMed ID: 1570873
[TBL] [Abstract][Full Text] [Related]
24. Reporting of adverse drug and biologic reactions in Mississippi hospitals.
Fincham JE; Brown TR; Garner DD
Hosp Pharm; 1988 Mar; 23(3):248-51. PubMed ID: 10286840
[TBL] [Abstract][Full Text] [Related]
25. A prospective study of adverse drug reactions in a dermatology department.
Ganeva M; Gancheva T; Lazarova R; Tzvetanova Y; Hristakieva E
Methods Find Exp Clin Pharmacol; 2007 Mar; 29(2):107-12. PubMed ID: 17440627
[TBL] [Abstract][Full Text] [Related]
26. Concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients.
Corsonello A; Pedone C; Corica F; Mussi C; Carbonin P; Antonelli Incalzi R;
Arch Intern Med; 2005 Apr; 165(7):790-5. PubMed ID: 15824299
[TBL] [Abstract][Full Text] [Related]
27. A potential causal association mining algorithm for screening adverse drug reactions in postmarketing surveillance.
Ji Y; Ying H; Dews P; Mansour A; Tran J; Miller RE; Massanari RM
IEEE Trans Inf Technol Biomed; 2011 May; 15(3):428-37. PubMed ID: 21435986
[TBL] [Abstract][Full Text] [Related]
28. Triazolam use in a university medical center.
Schwinghammer TL; Young BG; Hirsh JD
Am J Hosp Pharm; 1992 Dec; 49(12):2939-43. PubMed ID: 1481797
[TBL] [Abstract][Full Text] [Related]
29. Anti-infectives-induced adverse drug reactions in hospitalized patients.
Gholami K; Parsa S; Shalviri G; Sharifzadeh M; Assasi N
Pharmacoepidemiol Drug Saf; 2005 Jul; 14(7):501-6. PubMed ID: 15844215
[TBL] [Abstract][Full Text] [Related]
30. Review of Canadian pharmacist involvement in adverse drug reaction reporting.
Taras-Zasowski KM; Einarson TR
Can J Hosp Pharm; 1989 Jun; 42(3):105-8, 133. PubMed ID: 10318271
[TBL] [Abstract][Full Text] [Related]
31. A description of a successful computerized adverse drug reaction tracking program.
Maliekal J; Thornton J
Hosp Formul; 1990 Apr; 25(4):436-9, 442. PubMed ID: 10104234
[TBL] [Abstract][Full Text] [Related]
32. Clinical pharmacy services, pharmacy staffing, and adverse drug reactions in United States hospitals.
Bond CA; Raehl CL
Pharmacotherapy; 2006 Jun; 26(6):735-47. PubMed ID: 16716127
[TBL] [Abstract][Full Text] [Related]
33. [Can the screening of blood samples identify adverse drug reactions?].
Buajordet I; Laake K; Brørs O
Tidsskr Nor Laegeforen; 2007 Jun; 127(12):1637-9. PubMed ID: 17571101
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of adverse drug reactions with commonly prescribed drugs in different hospitals of Kathmandu valley.
Jha N; Bajracharya O; Namgyal T
Kathmandu Univ Med J (KUMJ); 2007; 5(4):504-10. PubMed ID: 18604084
[TBL] [Abstract][Full Text] [Related]
35. A team approach to adverse drug reaction surveillance: success at a tertiary care hospital.
Saltiel E; Johnson E; Shane R
Hosp Formul; 1995 Apr; 30(4):226-8, 231-2. PubMed ID: 10141866
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic E-codes for commonly used, narrow therapeutic index medications poorly predict adverse drug events.
Leonard CE; Haynes K; Localio AR; Hennessy S; Tjia J; Cohen A; Kimmel SE; Feldman HI; Metlay JP
J Clin Epidemiol; 2008 Jun; 61(6):561-71. PubMed ID: 18471660
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of acute reactions to iopromide: postmarketing surveillance study of 74,717 patients.
Kopp AF; Mortele KJ; Cho YD; Palkowitsch P; Bettmann MA; Claussen CD
Acta Radiol; 2008 Oct; 49(8):902-11. PubMed ID: 18651252
[TBL] [Abstract][Full Text] [Related]
38. A survey of adverse drug reaction reporting programs in select hospitals.
Case RL; Guzzetti PJ
Hosp Pharm; 1986 May; 21(5):423-6, 431-4, 438. PubMed ID: 10276799
[TBL] [Abstract][Full Text] [Related]
39. Adverse drug reaction monitoring: comparing doctor and patient reporting for new drugs.
Jarernsiripornkul N; Kakaew W; Loalukkana W; Krska J
Pharmacoepidemiol Drug Saf; 2009 Mar; 18(3):240-5. PubMed ID: 19148880
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of an adverse drug reaction electronic reporting system integrated into a hospital information system.
Ortega A; Aguinagalde A; Lacasa C; Aquerreta I; Fernández-Benítez M; Fernández LM
Ann Pharmacother; 2008 Oct; 42(10):1491-6. PubMed ID: 18780808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
